Immediate Impact

5 from Science/Nature 58 standout
Sub-graph 1 of 24

Citing Papers

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
2 intermediate papers

Works of Josef Singer being referenced

Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review
2020
Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients
2013

Author Peers

Author Last Decade Papers Cites
Josef Singer 255 228 164 258 40 810
E. Kownatzki 113 91 61 501 49 964
Daniel L. Kisner 246 70 136 188 33 979
Yūko Kikuchi 64 90 79 201 57 701
Cinzia Ricci 280 98 194 321 42 897
Kenneth Verstraete 120 48 92 341 25 968
Naofumi Takahashi 79 112 54 217 61 812
J Fujimoto 151 126 96 251 30 887
Bhabadeb Chowdhury 73 54 135 371 35 904
Zhenhua Wu 182 46 146 272 47 909
Sterling K. Ainsworth 55 73 88 163 43 899

All Works

Loading papers...

Rankless by CCL
2026